Sickle Cell Disease Trial, Recruiting (NCT07222475)

Sickle Cell Disease Trial, Recruiting NCT07222475 Sponsor: Mayo Clinic Condition: Sickle Cell Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07222475 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sickle Cell Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adolescents who are between 11 and 18 years old at the time of joining and able to give their agreement to participate
People who have been diagnosed with any type of sickle cell disease
People who are currently receiving care at a pediatric (children's) health centre
People who are able to read and write in English

Who may not be able to join:

People whose care has already moved from a children's facility to an adult facility
People with vision, hearing, or cognitive (thinking and understanding) difficulties that may make it hard to take part in the songwriting activities or complete the study measures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: C. Robert Bennett, PhD, Mayo Clinic

Phone: 507-422-5523

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07222475

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Sickle Cell Disease

Trial contact: 507-422-5523

More information: https://clinicaltrials.gov/study/NCT07222475

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adolescents who are between 11 and 18 years old at the time of joining and able to give their agreement to participate
People who have been diagnosed with any type of sickle cell disease
People who are currently receiving care at a pediatric (children's) health centre
People who are able to read and write in English

Who may not be able to join:

People whose care has already moved from a children's facility to an adult facility
People with vision, hearing, or cognitive (thinking and understanding) difficulties that may make it hard to take part in the songwriting activities or complete the study measures

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

5 February 2026

Est. completion

31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in State-Trait Anxiety Inventory score; Change in Patient Health Questionnaire (PHQ-A) score Change in Patient Health Questionnaire for Adolescents (PHQ-A) score; Change in Connor Davidson Resilience Scale (CD-RISC 10) score; Change in Difficulties in Emotion Regulation Scale (DERS-SF) score; Change in PROMIS Pediatric Pain Behavior (SF-8a) score; Change in PROMIS Pediatric Pain Quality - Affective (SF-8a) score; Change in PROMIS Pediatric Pain Quality - Sensory (SF-8a) score; Change in PROMIS Pediatric Physical Stress Experiences (SF-8a) score; Change in PROMIS Pediatric Psychological...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov